These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8794825)

  • 1. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure.
    Nakamura Y; Morishita R; Nakamura S; Aoki M; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1996 Sep; 28(3):409-13. PubMed ID: 8794825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension.
    Nakamura S; Moriguchi A; Morishita R; Aoki M; Yo Y; Hayashi S; Nakano N; Katsuya T; Nakata S; Takami S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Biochem Biophys Res Commun; 1998 Jan; 242(1):238-43. PubMed ID: 9439642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes.
    Morishita R; Nakamura S; Nakamura Y; Aoki M; Moriguchi A; Kida I; Yo Y; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Diabetes; 1997 Jan; 46(1):138-42. PubMed ID: 8971094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
    Nakano N; Moriguchi A; Morishita R; Kida I; Tomita N; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor.
    Nakamura Y; Morishita R; Higaki J; Kida I; Aoki M; Moriguchi A; Yamada K; Hayashi S; Yo Y; Nakano H; Matsumoto K; Nakamura T; Ogihara T
    J Hypertens; 1996 Sep; 14(9):1067-72. PubMed ID: 8986905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of a novel vascular modulator, hepatocyte growth factor (HGF), in cardiovascular disease: characterization and regulation of local HGF system.
    Morishita R; Aoki M; Nakamura S; Matsushita H; Tomita N; Hayashi S; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    J Atheroscler Thromb; 1997; 4(1):12-9. PubMed ID: 9583349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor (HGF) as a potential index of severity of hypertension.
    Morishita R; Moriguchi A; Higaki J; Ogihara T
    Hypertens Res; 1999 Sep; 22(3):161-7. PubMed ID: 10515437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of a vascular modulator, hepatocyte growth factor (HGF), to the pathogenesis of cardiovascular disease.
    Morishita R; Nakamura S; Hayashi S; Aoki M; Matsushita H; Tomita N; Yamamoto K; Moriguchi A; Higaki J; Ogihara T
    J Atheroscler Thromb; 1998; 4(3):128-34. PubMed ID: 9730144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
    Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T
    Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.
    Nakano N; Morishita R; Moriguchi A; Nakamura Y; Hayashi SI; Aoki M; Kida I; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1998 Sep; 32(3):444-51. PubMed ID: 9740609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy causes a decrease in hepatocyte growth factor in hypertensive women.
    Tamama K; Sumino H; Ichikawa S; Kanda T; Kotajima N; Fukumura Y; Kurabayashi M; Murakami M
    J Hypertens; 2003 Jun; 21(6):1151-6. PubMed ID: 12777952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients.
    Komai N; Ohishi M; Morishita R; Moriguchi A; Kaibe M; Matsumoto K; Rakugi H; Higaki J; Ogihara T
    Am J Hypertens; 2002 Jun; 15(6):499-506. PubMed ID: 12074350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor as a potential index of complication in diabetes mellitus.
    Nakamura S; Morishita R; Moriguchi A; Yo Y; Nakamura Y; Hayashi S; Matsumoto K; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    J Hypertens; 1998 Dec; 16(12 Pt 2):2019-26. PubMed ID: 9886892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.
    Nakagami H; Morishita R; Yamamoto K; Taniyama Y; Aoki M; Matsumoto K; Nakamura T; Kaneda Y; Horiuchi M; Ogihara T
    Hypertension; 2001 Feb; 37(2 Pt 2):581-6. PubMed ID: 11230338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor and 24-hour ambulatory blood pressure monitoring.
    Hayashi Y; Saitoh S; Takagi S; Tuchihashi K; Miura T; Shimamoto K
    Hypertens Res; 2002 Sep; 25(5):655-60. PubMed ID: 12452315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease.
    Yo Y; Morishita R; Yamamoto K; Tomita N; Kida I; Hayashi S; Moriguchi A; Kato S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Kidney Int; 1998 Jan; 53(1):50-8. PubMed ID: 9452999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor.
    Makino H; Aoki M; Hashiya N; Yamasaki K; Hiraoka K; Shimizu H; Azuma J; Kurinami H; Ogihara T; Morishita R
    Hypertens Res; 2004 Feb; 27(2):85-91. PubMed ID: 15005271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity is associated with increased levels of circulating hepatocyte growth factor.
    Rehman J; Considine RV; Bovenkerk JE; Li J; Slavens CA; Jones RM; March KL
    J Am Coll Cardiol; 2003 Apr; 41(8):1408-13. PubMed ID: 12706940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.